YY
Publicaties op Oncologisch.com
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Behandeling of Patients with Unresectable or Metastatic, HR-Pos...
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Rece...
FDA-goedkeuring van fruquintinib bij refractair gemetastaseerd CRC